We are live on ! Find out more
GCM

Garland Capital Management Portfolio holdings

AUM $7.27M
1-Year Est. Return 14.85%
This Fund
S&P 500
This Quarter Est. Return
+11.51%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$118M
AUM Growth
+$5.98M
Cap. Flow
-$5.46M
Cap. Flow %
-4.63%
Top 10 Hldgs %
51.85%
Holding
30
New
Increased
22
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
PRU icon
Prudential Financial
PRU
+$99.3K
2
CVS icon
CVS Health
CVS
+$61.8K
3
MMM icon
3M
MMM
+$51K
4
BNY
Bank of New York Mellon
BNY
+$40.3K
5
JPM icon
JPMorgan Chase
JPM
+$27.9K

Top Sells

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$3.69M
2
TTE icon
TotalEnergies
TTE
+$1.97M
3
PFE icon
Pfizer
PFE
+$263K
4
XOM icon
ExxonMobil
XOM
+$20.6K
5
NVS icon
Novartis
NVS
+$17.5K

Sector Composition

Rank Sector Weight
1 Healthcare 27.28%
2 Industrials 18%
3 Financials 15.34%
4 Real Estate 13.22%
5 Consumer Staples 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
1
United Parcel Service
UPS
$89.9B
$7.36M 6.24%
43,725
+150
+0.3% +$25.3K
UNP icon
2
Union Pacific
UNP
$183B
$6.71M 5.69%
32,222
+100
+0.3% +$20K
JPM icon
3
JPMorgan Chase
JPM
$942B
$6.62M 5.61%
52,065
+250
+0.5% +$27.9K
PG icon
4
Procter & Gamble
PG
$333B
$6.58M 5.58%
47,280
+150
+0.3% +$21K
JNJ icon
5
Johnson & Johnson
JNJ
$640B
$6.16M 5.22%
39,162
+100
+0.3% +$14.8K
ABBV icon
6
AbbVie
ABBV
$456B
$5.98M 5.07%
55,845
+175
+0.3% +$16.8K
MRK icon
7
Merck
MRK
$369B
$5.54M 4.7%
71,028
+105
+0.1% +$8.03K
ARE icon
8
Alexandria Real Estate Equities
ARE
$9B
$5.44M 4.61%
30,530
+100
+0.3% +$16.5K
PFE icon
9
Pfizer
PFE
$160B
$5.39M 4.57%
146,550
-7,176
-5% -$263K
CSCO icon
10
Cisco
CSCO
$442B
$5.38M 4.56%
120,171
+400
+0.3% +$16.4K
PEP icon
11
PepsiCo
PEP
$191B
$5.29M 4.48%
35,672
+50
+0.1% +$7.11K
NVS icon
12
Novartis
NVS
$294B
$4.79M 4.06%
50,705
-200
-0.4% -$17.5K
MMM icon
13
3M
MMM
$92.2B
$4.37M 3.7%
29,876
+359
+1% +$51K
CVS icon
14
CVS Health
CVS
$119B
$4.32M 3.66%
63,200
+950
+2% +$61.8K
PRU icon
15
Prudential Financial
PRU
$41.5B
$3.98M 3.38%
51,049
+1,374
+3% +$99.3K
IBM icon
16
IBM
IBM
$225B
$3.95M 3.35%
32,840
+157
+0.5% +$18.1K
BNY
17
Bank of New York Mellon
BNY
$110B
$3.85M 3.27%
90,800
+1,050
+1% +$40.3K
NTRS icon
18
Northern Trust
NTRS
$34.1B
$3.65M 3.09%
39,175
+125
+0.3% +$11K
PSA icon
19
Public Storage
PSA
$58.1B
$3.59M 3.04%
15,556
WELL icon
20
Welltower
WELL
$173B
$3.58M 3.04%
55,445
CVX icon
21
Chevron
CVX
$392B
$3.5M 2.96%
41,380
+50
+0.1% +$4.05K
T icon
22
AT&T
T
$174B
$3.19M 2.71%
147,084
+198
+0.1% +$4.27K
HIW icon
23
Highwoods Properties
HIW
$3.46B
$2.98M 2.53%
75,300
+150
+0.2% +$5.42K
RTX icon
24
RTX Corp
RTX
$286B
$2.8M 2.37%
39,182
+150
+0.4% +$9.86K
XOM icon
25
ExxonMobil
XOM
$643B
$2.17M 1.84%
52,657
-550
-1% -$20.6K

Similar funds

Garland Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Garland Capital Management held 30 positions worth $118M, up 5.3% from $112M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Garland Capital Management withdrew a net $5.46M in Q4 2020, closing 2 positions and reducing 3 holdings. Its most notable exit was Travelers Companies, an estimated $3.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Financials.

Against the trend, Garland Capital Management added an estimated $99.3K to Prudential Financial.

  • Garland Capital Management added most to Prudential Financial in Q4 2020, an estimated $99.3K increase.
  • Garland Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $263K.
  • Garland Capital Management fully exited Travelers Companies in Q4 2020, selling an estimated $3.69M.
  • Garland Capital Management's ten largest holdings make up 52% of its $118M portfolio in Q4 2020.
  • Garland Capital Management opened 0 new positions and closed 2 in Q4 2020.
  • Garland Capital Management's portfolio value rose 5.3% quarter-over-quarter to $118M.

Based on Garland Capital Management's 13F filing for Q4 2020, filed 9 Feb 2021.